Great proactive video. Changing the endpoint to time to discharge SHOULD pay dividends compared to mortality especially since we showed a 166% improvement in our last trial. Switching to IV for our critical patients is going to save lives and help us to meet our endpoint. I think it’s pretty amazing that they were able to get the paperwork in order and convince the Brazil FDA to allow IV. Then when they had questions about Leronlimab in the IV bags, to handle that in such a quick fashion. I think the 13D crew would be scratching their heads and Dr Yo would be scratching Dr P’s, well head, and not know what to do. This management has been through storms and learned how to manage difficult seas. I’m going with them to captain this ship to Paradise island, where Longs get to relax and reap the rewards of our non wavering belief in this company and product. LFG!!!!